
Dr Jess Kerr-Gaffney
Research Associate
Research

Psychoactive Trials Group
Psychoactive Trials Group
News
Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium
New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...
Research

Psychoactive Trials Group
Psychoactive Trials Group
News
Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium
New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...